Related Experiment Video
Updated: Jan 3, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Preliminary clinical results for PET/MR compared with PET/CT in patients with nasopharyngeal carcinoma
Yong Cheng1, Le Bai2, Jingjie Shang1
1Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China.
Abstract:
The present study aimed to assess the performance of positron emission tomography‑magnetic resonance imaging (PET/MR) for the visualization and characterization of lesions. In addition, the present study investigated whether the apparent diffusion coefficient (ADC) and intravoxel incoherent motion parameters exhibited any significant correlation with standardized uptake values (SUV) in patients with nasopharyngeal carcinoma (NPC). A total of 35 patients with NPC underwent whole body PET‑computed tomography (CT) and head and neck MR imaging (MRI) scans using the PET/CT‑MRI system. Image quality, lesion conspicuity and the diagnostic confidence of PET/CT, T1 weighted (T1w) PET/MR and T2w PET/MR imaging were assessed. The true diffusion coefficient (D), the pseudo‑diffusion coefficient or diffusion within the microcirculation (D*), and the perfusion fraction or the contribution of water moving in the capillaries (f), and ADC, were calculated. The correlation between the ADC, D*, D and f values and the SUV were analyzed using Pearson's correlation analysis. Similar image quality was obtained using PET/CT, T1w PET/MR and T2w PET/MR imaging. However, the T1w PET/MR and T2w PET/MR imaging were more effective than PET/CT in analyzing the lesion conspicuity of the primary tumors and lymph nodes. In addition, T2w PET/MR imaging was more efficient than T1w PET/MR imaging in analyzing primary tumors and lymph nodes. Pearson's correlation analysis showed no significant correlation between the SUV and ADC, and D*, D and f values in NPC. The present results suggested that the application of PET/MR is feasible and could serve as a reliable alternative to PET/CT, while SUV and ADC, D*, D and f values were identified as independent biomarkers in NPC.
Insights
Positron emission tomography-magnetic resonance imaging (PET/MR) offers comparable image quality to PET/CT for nasopharyngeal carcinoma (NPC) detection. PET/MR enhances lesion visualization, but SUV values do not correlate with diffusion parameters in NPC patients.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Nasopharyngeal carcinoma (NPC) diagnosis and staging rely on imaging techniques.
- Positron emission tomography-computed tomography (PET/CT) is a standard imaging modality for NPC.
- Positron emission tomography-magnetic resonance imaging (PET/MR) offers potential advantages in soft tissue contrast and functional information.
Purpose of the Study:
- To evaluate the performance of PET/MR in visualizing and characterizing lesions in NPC patients.
- To investigate the correlation between apparent diffusion coefficient (ADC) and intravoxel incoherent motion (IVIM) parameters with standardized uptake values (SUV) in NPC.
Main Methods:
- 35 NPC patients underwent whole-body PET/CT and head and neck MRI scans.
- Image quality, lesion conspicuity, and diagnostic confidence were assessed for PET/CT, T1w PET/MR, and T2w PET/MR.
- Diffusion parameters (ADC, D, D*, f) and SUV were calculated and analyzed for correlation using Pearson's analysis.
Main Results:
- PET/MR (T1w and T2w) demonstrated superior lesion conspicuity compared to PET/CT for primary tumors and lymph nodes.
- T2w PET/MR was more effective than T1w PET/MR for analyzing primary tumors and lymph nodes.
- No significant correlation was found between SUV and ADC, D, D*, or f values in NPC patients.
Conclusions:
- PET/MR is a feasible and reliable alternative to PET/CT for NPC imaging.
- SUV and diffusion parameters (ADC, D, D*, f) can serve as independent biomarkers in NPC.
- Further research is warranted to explore the combined utility of these biomarkers for NPC management.

